WOK
BEARISH
$1.18
Live
WORK Medical Technology Group LTD · NASDAQ
$1.05
52W Range
$10800.0
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Confidence
95%
WOK presents a classic 'value trap' scenario, characterized by a stable Piotroski F-Score of 6/9 but catastrophic price performance. While the company maintains a low debt-to-equity ratio and a stable health score, it has suffered a near-total loss of market value (-100% over 1Y, 3Y, and 5Y). Negative revenue growth (-14.40%) and negative profit margins (-10.89%) suggest a failing business model despite the superficially low Price-to-Book (0.07) and Price-to-Sales (0.15) ratios.
Key Strengths
Stable Piotroski F-Score (6/9)
Low Debt/Equity ratio (0.30)
Positive Gross Margin (23.81%)
Current Ratio above 1.0 (1.71)
Extremely low valuation multiples (P/B 0.07)
Key Risks
Catastrophic price collapse (-100% 1Y change)
Negative revenue growth (-14.40% YoY)
Negative net and operating profit margins
Poor liquidity indicated by low Quick Ratio (0.39)
Complete lack of technical momentum (Technical Trend 0/100)
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare WOK against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning WOK from our newsroom.
Newest → oldest
No matching news yet.